My watch list
my.bionity.com  
Login  
Am Windfeld 35
83714 Miesbach
Germany
Tel.
+4980252867-700
Fax
+4980252867-777

Company Portrait

Acino is specialized on the development, registration and manufacture of generic and innovative pharmaceuticals using advanced drug delivery technologies for which Acino also holds patents.

With a focus on solid oral dosage forms with modified release of the active ingredient, transdermal therapeutic patches and biodegradable, subcutaneous implants, Acino supplies leading pharmaceutical companies throughout Europe. Acino offers the pharmaceuticals industry a comprehensive range of services from product development and registration to sourcing, contract manufacturing, packaging and logistics.

The Acino Group is headquartered in Basle, currently employs approximately 380 staff and generated annual net revenues of about CHF 230 million in 2008. Acino Holding Ltd., the Group’s parent, is listed on the SIX Swiss Exchange (SIX: ACIN).

Focus: Manufacturer

Industrial Sectors

  • Pharma

Contact / Request information

Contact the company and request further information free of charge:

Watchlist

This is where you can add this company to your personal favourites

More about Acino
  • Companies

    Acino Holding AG

    Acino is specialized on the development, registration and manufacture of generic and innovative pharmaceuticals using advanced drug delivery technologies for which Acino also holds patents. With a focus on solid oral dosage forms with modified release of the active ingredient, transdermal ... more

    Acino Pharma GmbH

    Acino is specialized on the development, registration and manufacture of generic and innovative pharmaceuticals using advanced drug delivery technologies for which Acino also holds patents. With a focus on solid oral dosage forms with modified release of the active ingredient, transdermal ... more

    Acino Pharma AG

    Acino is specialized on the development, registration and manufacture of generic and innovative pharmaceuticals using advanced drug delivery technologies for which Acino also holds patents. With a focus on solid oral dosage forms with modified release of the active ingredient, transdermal ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE